Transonic Systems Inc.

Transonic Systems Inc., based in Ithaca, New York, manufactures specialized medical measurement and monitoring devices for federal healthcare and research agencies, operating exclusively as a prime contractor on full-and-open and small-business set-aside purchase orders and delivery orders. The company is a for-profit manufacturer of goods classified under NAICS 339112 (Surgical and Medical Instrument Manufacturing) and PSC 6515 (Medical and Surgical Instruments, Equipment, and Supplies), with a 365-award federal footprint spanning nearly four decades.

Transonic's federal customer base concentrates heavily on the Department of Veterans Affairs and military medical services. The top five customer organizations by dollar potential value—Veterans Integrated Service Network 12, VISN 4, VISN 10, VISN 1, and the Navy Bureau of Medicine and Surgery—account for 69% of combined potential value across all awards, though this concentration masks a portfolio scattered across 30 distinct federal customer entities. The VA systems dominate both award volume and dollars; VISN 12 anchors the highest dollar concentration at 5 awards worth $4.1 million combined potential value, while VISN 4 leads by award count at 20 orders totaling $326 thousand. This split reveals the portfolio's character: a high-frequency, low-per-award supplier of medical devices to distributed VA and military medical facilities.

Transonic delivers hemodialysis monitors and sensors (HD03 series), blood flowmeters, ultrasonic flowmeter consoles, microflow probes, coronary and pressure catheters, and clinical measurement meters. Representative recent work includes a $61,425 sole-source purchase order from VISN 1 (April 2026) for two HD03 monitors, two H4FX sensors, and two patient measurement modules—the VA determined Transonic the only manufacturer of a standalone portable hemodialysis flow system meeting the specialized requirement without additional intravenous lines; a $74,700 purchase order from the Food and Drug Administration (September 2023) for ultrasonic flowmeter consoles under a Total Small Business set-aside; and a $39,568.64 delivery order from VISN 6 under the GSA Medical Equipment and Supplies (FSS-65-II-A) schedule (August 2024) for HD03 monitors. Transonic sits on the GSA Medical Equipment and Supplies schedule as its parent vehicle, with 15 task orders carrying $448 thousand in combined potential value.

Activity has decelerated in recent years—five awards in 2022, eight in 2023, three in 2024, two in 2025, and two in the first half of 2026—with only one award ($31 thousand combined potential value) completing within the next twenty-four months, presenting minimal recompete exposure in that window. The combined dollars obligated across all awards ($9.6 million) exceed the combined potential value ceiling ($7.7 million), indicating that invoiced performance has tracked above contract ceilings on some orders. Transonic competes on full-and-open and small-business set-aside basis without 8(a), HUBZone, SDVOSB, or other category-specific designations. The vendor maintains no subcontractor footprint in its federal work; all 365 awards are prime-contract awards.

Global manufacturer of precision biomedical measurement instruments, Gold Standard Transit Time ultrasound slow meters, ultrasound dilution monitors/laser doppler perfusion monitors, pressure volume, telemetry systems to clinicians, researchers worldwide